Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873

Watchlist Manager
Guiyang Xintian Pharmaceutical Co Ltd Logo
Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873
Watchlist
Price: 10 CNY -1.09% Market Closed
Market Cap: 2.4B CNY

Intrinsic Value

The intrinsic value of one Guiyang Xintian Pharmaceutical Co Ltd stock under the Base Case scenario is 5.18 CNY. Compared to the current market price of 10 CNY, Guiyang Xintian Pharmaceutical Co Ltd is Overvalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5.18 CNY
Overvaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Guiyang Xintian Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Guiyang Xintian Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Guiyang Xintian Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Guiyang Xintian Pharmaceutical Co Ltd.

Explain Valuation
Compare Guiyang Xintian Pharmaceutical Co Ltd to

Fundamental Analysis

Guiyang Xintian Pharmaceutical Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Guiyang Xintian Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Guiyang Xintian Pharmaceutical Co Ltd

Current Assets 560m
Cash & Short-Term Investments 94.6m
Receivables 311.1m
Other Current Assets 154.3m
Non-Current Assets 1.3B
Long-Term Investments 416.4m
PP&E 693.3m
Intangibles 194.4m
Other Non-Current Assets 19.9m
Current Liabilities 211.2m
Accounts Payable 82.3m
Accrued Liabilities 26.5m
Short-Term Debt 71m
Other Current Liabilities 31.3m
Non-Current Liabilities 486.4m
Long-Term Debt 440.6m
Other Non-Current Liabilities 45.8m
Efficiency

Free Cash Flow Analysis
Guiyang Xintian Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Guiyang Xintian Pharmaceutical Co Ltd

Revenue
755.3m CNY
Cost of Revenue
-226.9m CNY
Gross Profit
528.5m CNY
Operating Expenses
-506m CNY
Operating Income
22.5m CNY
Other Expenses
-15m CNY
Net Income
7.5m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Guiyang Xintian Pharmaceutical Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Low 3Y Average Operating Margin
Low 3Y Average Net Margin
44/100
Profitability
Score

Guiyang Xintian Pharmaceutical Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Guiyang Xintian Pharmaceutical Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
High Altman Z-Score
60/100
Solvency
Score

Guiyang Xintian Pharmaceutical Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Guiyang Xintian Pharmaceutical Co Ltd

There are no price targets for Guiyang Xintian Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Guiyang Xintian Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Guiyang Xintian Pharmaceutical Co Ltd stock?

The intrinsic value of one Guiyang Xintian Pharmaceutical Co Ltd stock under the Base Case scenario is 5.18 CNY.

Is Guiyang Xintian Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 10 CNY, Guiyang Xintian Pharmaceutical Co Ltd is Overvalued by 48%.

Back to Top